
Chief Commercialisation Officer
Jennie has over 30 years experience across the pharmaceutical and diagnostics industries, in commercialisation leadership roles.
Prior to joining LyoDx, she worked for QuantuMDx as VP Sales & Marketing, preparing markets for the introduction of their point-of-care platform. Previous to this, from 2014-2021, s
Chief Commercialisation Officer
Jennie has over 30 years experience across the pharmaceutical and diagnostics industries, in commercialisation leadership roles.
Prior to joining LyoDx, she worked for QuantuMDx as VP Sales & Marketing, preparing markets for the introduction of their point-of-care platform. Previous to this, from 2014-2021, she was Sales Director for Oxford Immunotec, a $74 million-revenue global high growth diagnostics company, leading the NW European sales teams and achieving double digit growth in a competitive specialised market.
With over 10 years spent within the field of tuberculosis (TB), she is looking forward to developing new diagnostics through partnerships and collaboration.

Scientific Affairs Manager
Alex began work in the IVD industry during the COVID-19 pandemic at the Integrated COVID Hub North East (ICHNE), where he was promoted to the role of Operations Manager with responsibility for a shift of up to 140 staff, processing up to 56,000 tests per day. He subsequently worked at QuantuMDx before joining Ly
Scientific Affairs Manager
Alex began work in the IVD industry during the COVID-19 pandemic at the Integrated COVID Hub North East (ICHNE), where he was promoted to the role of Operations Manager with responsibility for a shift of up to 140 staff, processing up to 56,000 tests per day. He subsequently worked at QuantuMDx before joining LyoDx.
Prior to this, Alex completed his undergraduate and masters degrees at the University of Cambridge before gaining his PhD in yeast genetics from the University of Exeter. A postdoctoral research position with Newcastle University brought him to the North East, where he has remained since.

Product Manager
Charlotte has over six years of experience in the diagnostics industry, spanning technical and commercial roles. She has worked across manufacturing, technical support and product management, supporting the development of PCR and lateral flow technologies.
.jpg/:/cr=t:11.18%25,l:16.35%25,w:52.63%25,h:52.63%25/rs=w:365,h:365,cg:true,m)
Principal Scientist
Catherine brings valuable academic experience in gene expression and immune responses, alongside industry expertise developing molecular diagnostic assays and lyophilisation.
Catherine holds a MSc from the University of Leeds and gained her PhD from Newcastle University, where she worked as a postdoctoral researcher for a further three years.